Securities code: 301087 securities abbreviation: Cofoe Medical Technology Co.Ltd(301087) Cofoe Medical Technology Co.Ltd(301087)
Record of investor relations activities
No.: 2022-001
Investor relations activity category □ specific object research □ analyst meeting
□ media interview □ performance briefing
□ press conference □ Roadshow
□ site visit
\uf0a3 others
Name and personnel of participating units China Industrial Securities Co.Ltd(601377) sun Yuanyuan, Liu Lu and Wang Jiahui; Sunshine asset Zhang Jianshu; Pu Yin Ansheng, Ma Yunyu; Name: Wu Jiaxin of Soochow Fund; Da Mo Huaxin, Zhao Weijie; China International Capital Corporation Limited(601995) Yang Zhongnan; Shen wanlingxin, Wang Qilin; Shanghai Securities Huang Zhuo, Xu Xin, Peng Yi.
Time: 2022-1-5 to 2022-1-7
Location Cofoe Medical Technology Co.Ltd(301087) conference room
Receptionists of listed companies surnamed chairman / president Zhang Min
Director / Vice President / Secretary Xue Xiaoqiao
1. How does the company quickly cut into Internet channels?
A: before the start of e-commerce for medical devices, the company had a deep accumulation of offline channels, products and brands. As an early enterprise in China that obtained the Internet B2B and B2C trading licenses for medical devices, the company is an early enterprise in the industry to start internet sales, and has successively completed the layout of China’s main third-party e-commerce platforms, deeply covering online consumers.
Through the accumulation of many years of online store operation experience, the company’s online operators and team size have reached a high level in the main industries of investor relations activities, and have good warehouse management and after-sales service capabilities. At the same time, the company adheres to the channel self introduction business, without distribution and agency, which can give full play to the company’s operation advantages. In recent years, the company’s online sales revenue and accumulated users have increased year by year, and the online channel has become the fastest-growing sales channel of the company. 2. What is the company’s R & D team and R & D focus?
A: at present, the company has more than 200 R & D personnel and has three research institutes, medical electronics and Rehabilitation Medicine Research Institute, biosensor and innovative materials research institute and Shenzhen Research Institute, which are committed to the exploration and research of multiple application fields and product types such as rehabilitation medicine, vital signs and biosensor. At present, the company has a number of research projects, among which the key projects include continuous blood glucose monitoring of health monitoring, key technologies of dynamic multi parameter, the third generation audiometer, real ear analyzer, etc., which has formed an industrialization echelon and continuously created value for the company.
3. Will the company’s self production proportion and future improvement plan increase the gross profit margin accordingly in 2021? A: in recent years, the company has continuously increased its investment in technology R & D, production sites, machinery, equipment and personnel, improved the utilization rate of production line capacity, as well as the types and capacity of self-produced products. The proportion of independent production has been increasing, which has further improved the gross profit. At present, the company’s revenue from self-produced products accounts for more than 50%. In the future, with the further improvement of the company’s R & D investment and the continuous production of Changsha and Yueyang production bases, the company’s proportion of self-produced products will further increase.
4. How is the company’s CGM R & D progress?
A: the company’s CGM product research and development has been carried out for more than a year. At present, it is in the pre experimental stage. The company will carry out follow-up trial production, registration inspection and other work in an orderly manner.
5. What is the future development prospect of hearing aid fitting industry and the future development plan of the company?
A: at present, the wearing rate of hearing aids in China is less than 5%, while that in developed countries such as Europe and the United States has reached 30% or even higher. At the same time, with the intensification of China’s aging, the improvement of residents’ income level and the change of consumption concept, there is a very broad space for the development of China’s hearing aid market in the future.
At present, the company is accelerating the opening plan of jianermen store. In the future, it will gradually start from hearing aid fitting service to the R & D and production of hearing equipment and hearing aids, open the closed loop of the industrial chain and establish its own competitive advantage.
6. What are the customer portraits of Jianer store and the channels for obtaining customers?
A: more than 90% of the stores are middle-aged and elderly customers. Stores mainly carry out various types of Wuxi Online Offline Communication Information Technology Co.Ltd(300959) promotion and publicity activities through shop recruitment, community promotion, public welfare education, and Baidu tiktok.
7. What are the differences between Jianer chain stores and individual stores?
A: the hearing aid fitting industry is still in the early stage of development. The degree of chain stores is low and the service quality is uneven. Professional brand chain stores can enable consumers to get a better service experience.
The company entered this industry from 2011 until the establishment of Jianer hearing in 2018 to carry out independent brand operation. Over the years, the company has been exploring and polishing the operation management system of hearing aid business, including store location, operation and training system. At present, Jianer hearing stores adopt the direct chain mode. Through “family service process”, “Nine Star fitting process” and “lifelong after-sales service”, Jianer hearing stores realize differentiated operation with other hearing aid fitting stores in terms of specialty, service and management, and popularize and develop through stores Wuxi Online Offline Communication Information Technology Co.Ltd(300959) market promotion to shape the “Jianer” brand, and establish a good brand awareness and high industry status.
Annex list (if any) none
Date: January 7, 2022
